{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:15:02Z","timestamp":1791314102070,"version":"4.3.1"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["755306"],"award-info":[{"award-number":["755306"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","award":["208263-2019"],"award-info":[{"award-number":["208263-2019"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"name":"grants received from Liaison Committee between the Central Norway Regional Health Authority (RHA) and NTNU and Terje Eugen Johnsen funds, Norway"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Understanding the characteristics of the tumor microenvironment (TME) associated with aggressive prostate cancer (PCa) is essential for accurate diagnosis and treatment. We interrogated spatially resolved multi-omics data to find molecular stratifiers of aggressive PCa. We report an aggressive prostate cancer (APC) gene expression signature predictive of increased risk of relapse and metastasis in a cohort of 1,588 patients. Further, we present a chemokine-enriched-gland (CEG) signature specific to non-cancerous prostatic glands from patients with aggressive cancer. The CEG signature is characterized by upregulated expression of pro-inflammatory chemokines, club-like cell enrichment, and immune cell infiltration of surrounding stroma. The activity of both signatures is correlated with reduced citrate and zinc levels and loss of normal prostate secretory gland functions. In summary we report that an increased inflammatory status linked to chemokine production, club-like cell enrichment, and metabolic changes in normal-appearing prostatic glands is associated with the subsequent development of aggressive PCa.<\/jats:p>","DOI":"10.1038\/s41467-025-65161-9","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:59:27Z","timestamp":1763557167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Spatial multi-omics identifies aggressive prostate cancer signatures highlighting pro-inflammatory chemokine activity in the tumor microenvironment"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1959-0130","authenticated-orcid":false,"given":"Sebastian","family":"Krossa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2883-2450","authenticated-orcid":false,"given":"Maria K.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise M.","family":"Sandholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4227-6569","authenticated-orcid":false,"given":"Maximilian","family":"Wess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7419-0773","authenticated-orcid":false,"given":"Antti","family":"Kiviaho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5513-6210","authenticated-orcid":false,"given":"Abhibhav","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sini","family":"Hakkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alshalalfa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elai","family":"Davicioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trond","family":"Viset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"St\u00f8rkersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Jeffrey","family":"Karnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5973-4741","authenticated-orcid":false,"given":"Daniel E.","family":"Spratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2157-8824","authenticated-orcid":false,"given":"Guro F.","family":"Giske\u00f8deg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6956-2843","authenticated-orcid":false,"given":"Matti","family":"Nykter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten B.","family":"Rye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Urbanucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5734-2157","authenticated-orcid":false,"given":"May-Britt","family":"Tessem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"65161_CR1","doi-asserted-by":"crossref","unstructured":"Pernar, C. H., Ebot, E. M., Wilson, K. M. & Mucci, L. A. The epidemiology of prostate cancer. Cold Spring Harb. Perspect. Med. 8, a030361 (2018).","DOI":"10.1101\/cshperspect.a030361"},{"key":"65161_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41585-020-00400-w","volume":"18","author":"MC Haffner","year":"2021","unstructured":"Haffner, M. C. et al. Genomic and phenotypic heterogeneity in prostate cancer. Nat. Rev. Urol. 18, 79\u201392 (2021).","journal-title":"Nat. Rev. Urol."},{"key":"65161_CR3","doi-asserted-by":"crossref","unstructured":"Shore, N. D. et al. Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification. Prostate Cancer Prostatic Dis. 27, 192\u2013201 (2023).","DOI":"10.1038\/s41391-023-00712-z"},{"key":"65161_CR4","doi-asserted-by":"publisher","first-page":"676716","DOI":"10.3389\/fonc.2021.676716","volume":"11","author":"SP Basourakos","year":"2021","unstructured":"Basourakos, S. P. et al. Tissue-based biomarkers for the risk stratification of men with clinically localized prostate cancer. Front. Oncol. 11, 676716 (2021).","journal-title":"Front. Oncol."},{"key":"65161_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27322-4","volume":"13","author":"H Song","year":"2022","unstructured":"Song, H. et al. Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states. Nat. Commun. 13, 141 (2022).","journal-title":"Nat. Commun."},{"key":"65161_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36325-2","volume":"14","author":"T Hirz","year":"2023","unstructured":"Hirz, T. et al. Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses. Nat. Commun. 14, 663 (2023).","journal-title":"Nat. Commun."},{"key":"65161_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04724-5","volume":"9","author":"E Berglund","year":"2018","unstructured":"Berglund, E. et al. Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity. Nat. Commun. 9, 2419 (2018).","journal-title":"Nat. Commun."},{"key":"65161_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41586-022-05023-2","volume":"608","author":"A Erickson","year":"2022","unstructured":"Erickson, A. et al. Spatially resolved clonal copy number alterations in benign and malignant tissue. Nature 608, 360\u2013367 (2022).","journal-title":"Nature"},{"key":"65161_CR9","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1016\/j.celrep.2018.11.086","volume":"25","author":"GH Henry","year":"2018","unstructured":"Henry, G. H. et al. A cellular anatomy of the normal adult human prostate and prostatic urethra. Cell Rep. 25, 3530\u20133542.e3535 (2018).","journal-title":"Cell Rep."},{"key":"65161_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/path.5751","volume":"255","author":"DB Joseph","year":"2021","unstructured":"Joseph, D. B. et al. Single-cell analysis of mouse and human prostate reveals novel fibroblasts with specialized distribution and microenvironment interactions. J. Pathol. 255, 141\u2013154 (2021).","journal-title":"J. Pathol."},{"key":"65161_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-2559.2011.04033.x","volume":"60","author":"KS Sfanos","year":"2012","unstructured":"Sfanos, K. S. & De Marzo, A. M. Prostate cancer and inflammation: the evidence. Histopathology 60, 199\u2013215 (2012).","journal-title":"Histopathology"},{"key":"65161_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41568-020-0267-9","volume":"20","author":"JS de Bono","year":"2020","unstructured":"de Bono, J. S. et al. Prostate carcinogenesis: inflammatory storms. Nat. Rev. Cancer 20, 455\u2013469 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"65161_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41586-018-0393-7","volume":"560","author":"DT Montoro","year":"2018","unstructured":"Montoro, D. T. et al. A revised airway epithelial hierarchy includes CFTR-expressing ionocytes. Nature 560, 319\u2013324 (2018).","journal-title":"Nature"},{"key":"65161_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41525-021-00237-1","volume":"6","author":"MR Rostami","year":"2021","unstructured":"Rostami, M. R. et al. Smoking shifts human small airway epithelium club cells toward a lesser differentiated population. NPJ Genom. Med. 6, 73 (2021).","journal-title":"NPJ Genom. Med."},{"key":"65161_CR15","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/pros.24020","volume":"80","author":"DB Joseph","year":"2020","unstructured":"Joseph, D. B. et al. Urethral luminal epithelia are castration-insensitive cells of the proximal prostate. Prostate 80, 872\u2013884 (2020).","journal-title":"Prostate"},{"key":"65161_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/path.6149","volume":"261","author":"FW Huang","year":"2023","unstructured":"Huang, F. W. et al. Club-like cells in proliferative inflammatory atrophy of the prostate. J. Pathol. 261, 85\u201395 (2023).","journal-title":"J. Pathol."},{"key":"65161_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/path.5857","volume":"256","author":"DB Joseph","year":"2022","unstructured":"Joseph, D. B. et al. 5-Alpha reductase inhibitors induce a prostate luminal to club cell transition in human benign prostatic hyperplasia. J. Pathol. 256, 427\u2013441 (2022).","journal-title":"J. Pathol."},{"key":"65161_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1126\/science.aay0267","volume":"368","author":"WR Karthaus","year":"2020","unstructured":"Karthaus, W. R. et al. Regenerative potential of prostate luminal cells revealed by single-cell analysis. Science 368, 497\u2013505 (2020).","journal-title":"Science"},{"key":"65161_CR19","doi-asserted-by":"crossref","unstructured":"Germanos, A. A. et al. Defining cellular population dynamics at single-cell resolution during prostate cancer progression. Elife 11, e79076 (2022).","DOI":"10.7554\/eLife.79076"},{"key":"65161_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54364-1","volume":"15","author":"A Kiviaho","year":"2024","unstructured":"Kiviaho, A. et al. Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer. Nat. Commun. 15, 9949 (2024).","journal-title":"Nat. Commun."},{"key":"65161_CR21","doi-asserted-by":"publisher","first-page":"e62375","DOI":"10.1371\/journal.pone.0062375","volume":"8","author":"GF Giskeodegard","year":"2013","unstructured":"Giskeodegard, G. F. et al. Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness. PLoS ONE 8, e62375 (2013).","journal-title":"PLoS ONE"},{"key":"65161_CR22","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1021\/acs.analchem.9b04903","volume":"92","author":"MK Andersen","year":"2020","unstructured":"Andersen, M. K. et al. Simultaneous detection of zinc and its pathway metabolites using MALDI MS imaging of prostate tissue. Anal. Chem. 92, 3171\u20133179 (2020).","journal-title":"Anal. Chem."},{"key":"65161_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrrheum.2017.37","volume":"13","author":"T Gaber","year":"2017","unstructured":"Gaber, T., Strehl, C. & Buttgereit, F. Metabolic regulation of inflammation. Nat. Rev. Rheumatol. 13, 267\u2013279 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"65161_CR24","doi-asserted-by":"publisher","first-page":"e0153727","DOI":"10.1371\/journal.pone.0153727","volume":"11","author":"MB Tessem","year":"2016","unstructured":"Tessem, M. B. et al. A balanced tissue composition reveals new metabolic and gene expression markers in prostate cancer. PLoS ONE 11, e0153727 (2016).","journal-title":"PLoS ONE"},{"key":"65161_CR25","doi-asserted-by":"publisher","first-page":"21276","DOI":"10.1073\/pnas.1117029108","volume":"108","author":"EK Markert","year":"2011","unstructured":"Markert, E. K., Mizuno, H., Vazquez, A. & Levine, A. J. Molecular classification of prostate cancer using curated expression signatures. Proc. Natl. Acad. Sci. USA 108, 21276\u201321281 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"65161_CR26","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s42003-020-01247-y","volume":"3","author":"A Andersson","year":"2020","unstructured":"Andersson, A. et al. Single-cell and spatial transcriptomics enables probabilistic inference of cell type topography. Commun. Biol. 3, 565 (2020).","journal-title":"Commun. Biol."},{"key":"65161_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","volume":"23","author":"S Chen","year":"2021","unstructured":"Chen, S. et al. Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat. Cell Biol. 23, 87\u201398 (2021).","journal-title":"Nat. Cell Biol."},{"key":"65161_CR28","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s42003-020-01476-1","volume":"3","author":"B Dong","year":"2020","unstructured":"Dong, B. et al. Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer. Commun. Biol. 3, 778 (2020).","journal-title":"Commun. Biol."},{"key":"65161_CR29","first-page":"161","volume":"14","author":"AA Karami","year":"2022","unstructured":"Karami, A. A. et al. Detection of bacterial agents causing prostate infection by culture and molecular methods from biopsy specimens. Iran. J. Microbiol 14, 161\u2013167 (2022).","journal-title":"Iran. J. Microbiol"},{"key":"65161_CR30","doi-asserted-by":"crossref","unstructured":"Wess, M. et al. Spatial integration of multi-omics data from serial sections using the novel Multi-Omics Imaging Integration Toolset. Gigascience 14, giaf035 (2025).","DOI":"10.1093\/gigascience\/giaf035"},{"key":"65161_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.4103\/1008-682X.175096","volume":"18","author":"R Na","year":"2016","unstructured":"Na, R., Wu, Y., Ding, Q. & Xu, J. Clinically available RNA profiling tests of prostate tumors: utility and comparison. Asian J. Androl. 18, 575\u2013579 (2016).","journal-title":"Asian J. Androl."},{"key":"65161_CR32","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1007\/s00262-021-02923-6","volume":"70","author":"D Lv","year":"2021","unstructured":"Lv, D. et al. A novel immune-related gene-based prognostic signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy. Cancer Immunol. Immunother. 70, 3587\u20133602 (2021).","journal-title":"Cancer Immunol. Immunother."},{"key":"65161_CR33","doi-asserted-by":"publisher","first-page":"982628","DOI":"10.3389\/fimmu.2022.982628","volume":"13","author":"H Li","year":"2022","unstructured":"Li, H. et al. A prognostic signature consisting of metabolism-related genes and SLC17A4 serves as a potential biomarker of immunotherapeutic prediction in prostate cancer. Front. Immunol. 13, 982628 (2022).","journal-title":"Front. Immunol."},{"key":"65161_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-01672-3","volume":"29","author":"B Hu","year":"2024","unstructured":"Hu, B. et al. Identification and validation of an individualized metabolic prognostic signature for predicting the biochemical recurrence of prostate cancer based on the immune microenvironment. Eur. J. Med. Res. 29, 92 (2024).","journal-title":"Eur. J. Med. Res."},{"key":"65161_CR35","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1038\/s41416-024-02854-w","volume":"131","author":"M Shen","year":"2024","unstructured":"Shen, M. et al. Identification of a 5-gene signature panel for the prediction of prostate cancer progression. Br. J. Cancer 131, 1748\u20131761 (2024).","journal-title":"Br. J. Cancer"},{"key":"65161_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00018-008-8321-x","volume":"66","author":"E Malle","year":"2009","unstructured":"Malle, E., Sodin-Semrl, S. & Kovacevic, A. Serum amyloid A: an acute-phase protein involved in tumour pathogenesis. Cell Mol. Life Sci. 66, 9\u201326 (2009).","journal-title":"Cell Mol. Life Sci."},{"key":"65161_CR37","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1373\/clinchem.2004.041087","volume":"51","author":"L Le","year":"2005","unstructured":"Le, L. et al. Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions. Clin. Chem. 51, 695\u2013707 (2005).","journal-title":"Clin. Chem."},{"key":"65161_CR38","doi-asserted-by":"publisher","first-page":"4897","DOI":"10.2147\/IJGM.S355435","volume":"15","author":"J Wei","year":"2022","unstructured":"Wei, J. et al. Identification of potential predictor of biochemical recurrence in prostate cancer. Int. J. Gen. Med. 15, 4897\u20134905 (2022).","journal-title":"Int. J. Gen. Med."},{"key":"65161_CR39","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/oxfordjournals.jbchem.a123634","volume":"110","author":"S Isemura","year":"1991","unstructured":"Isemura, S., Saitoh, E., Sanada, K. & Minakata, K. Identification of full-sized forms of salivary (S-type) cystatins (cystatin SN, cystatin SA, cystatin S, and two phosphorylated forms of cystatin S) in human whole saliva and determination of phosphorylation sites of cystatin S. J. Biochem. 110, 648\u2013654 (1991).","journal-title":"J. Biochem."},{"key":"65161_CR40","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ijbiomac.2017.04.071","volume":"102","author":"A Shamsi","year":"2017","unstructured":"Shamsi, A. & Bano, B. Journey of cystatins from being mere thiol protease inhibitors to at heart of many pathological conditions. Int. J. Biol. Macromol. 102, 674\u2013693 (2017).","journal-title":"Int. J. Biol. Macromol."},{"key":"65161_CR41","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.7150\/jca.53983","volume":"12","author":"Q Xie","year":"2021","unstructured":"Xie, Q. et al. Identification of cysteine protease inhibitor CST2 as a potential biomarker for colorectal cancer. J. Cancer 12, 5144\u20135152 (2021).","journal-title":"J. Cancer"},{"key":"65161_CR42","doi-asserted-by":"publisher","first-page":"692117","DOI":"10.3389\/fonc.2021.692117","volume":"11","author":"Q Zhao","year":"2021","unstructured":"Zhao, Q., Cheng, Y. & Xiong, Y. LTF regulates the immune microenvironment of prostate cancer through JAK\/STAT3 pathway. Front. Oncol. 11, 692117 (2021).","journal-title":"Front. Oncol."},{"key":"65161_CR43","doi-asserted-by":"crossref","unstructured":"Qiu, K., Ding, D., Zhang, F. & Yang, B. LTF as a potential prognostic and immunological biomarker in glioblastoma. Biochem. Genet. 63, 2347\u20132362 (2024).","DOI":"10.1007\/s10528-024-10716-6"},{"key":"65161_CR44","doi-asserted-by":"publisher","first-page":"155214","DOI":"10.1016\/j.cyto.2020.155214","volume":"135","author":"SK Schroder","year":"2020","unstructured":"Schroder, S. K., Asimakopoulou, A., Tillmann, S., Koschmieder, S. & Weiskirchen, R. TNF-alpha controls Lipocalin-2 expression in PC-3 prostate cancer cells. Cytokine 135, 155214 (2020).","journal-title":"Cytokine"},{"key":"65161_CR45","doi-asserted-by":"crossref","unstructured":"Schroder, S. K., Pinoe-Schmidt, M. & Weiskirchen, R. Lipocalin-2 (LCN2) deficiency leads to cellular changes in highly metastatic human prostate cancer cell line PC-3. Cells 11, 260 (2022).","DOI":"10.3390\/cells11020260"},{"key":"65161_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-019-0434-3","volume":"17","author":"Y Lu","year":"2019","unstructured":"Lu, Y. et al. CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition. Cell Commun. Signal. 17, 118 (2019).","journal-title":"Cell Commun. Signal."},{"key":"65161_CR47","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/sj.bjc.6601570","volume":"90","author":"ME Legrier","year":"2004","unstructured":"Legrier, M. E. et al. Mucinous differentiation features associated with hormonal escape in a human prostate cancer xenograft. Br. J. Cancer 90, 720\u2013727 (2004).","journal-title":"Br. J. Cancer"},{"key":"65161_CR48","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1080\/02841860801961265","volume":"47","author":"M Abdul","year":"2008","unstructured":"Abdul, M., McCray, S. D. & Hoosein, N. M. Expression of gamma-aminobutyric acid receptor (subtype A) in prostate cancer. Acta Oncol. 47, 1546\u20131550 (2008).","journal-title":"Acta Oncol."},{"key":"65161_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08021-1","volume":"21","author":"HTN Nguyen","year":"2021","unstructured":"Nguyen, H. T. N. et al. Reference-free transcriptome signatures for prostate cancer prognosis. BMC Cancer 21, 394 (2021).","journal-title":"BMC Cancer"},{"key":"65161_CR50","doi-asserted-by":"publisher","first-page":"876531","DOI":"10.3389\/fonc.2022.876531","volume":"12","author":"L Tang","year":"2022","unstructured":"Tang, L. et al. Mutator-derived lncRNA landscape: a novel insight into the genomic instability of prostate cancer. Front. Oncol. 12, 876531 (2022).","journal-title":"Front. Oncol."},{"key":"65161_CR51","doi-asserted-by":"publisher","first-page":"16189","DOI":"10.1074\/jbc.M111936200","volume":"277","author":"S Tang","year":"2002","unstructured":"Tang, S. et al. Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells. J. Biol. Chem. 277, 16189\u201316201 (2002).","journal-title":"J. Biol. Chem."},{"key":"65161_CR52","doi-asserted-by":"publisher","first-page":"104451","DOI":"10.1016\/j.isci.2022.104451","volume":"25","author":"MB Rye","year":"2022","unstructured":"Rye, M. B. et al. The genes controlling normal function of citrate and spermine secretion are lost in aggressive prostate cancer and prostate model systems. iScience 25, 104451 (2022).","journal-title":"iScience"},{"key":"65161_CR53","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/bjc.2012.549","volume":"108","author":"KD Sorensen","year":"2013","unstructured":"Sorensen, K. D. et al. Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer. Br. J. Cancer 108, 420\u2013428 (2013).","journal-title":"Br. J. Cancer"},{"key":"65161_CR54","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bbamcr.2018.06.016","volume":"1866","author":"CE Nunes-Xavier","year":"2019","unstructured":"Nunes-Xavier, C. E., Mingo, J., Lopez, J. I. & Pulido, R. The role of protein tyrosine phosphatases in prostate cancer biology. Biochim. Biophys. Acta Mol. Cell Res. 1866, 102\u2013113 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"65161_CR55","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41420-024-01930-7","volume":"10","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. NCAPD3 exerts tumor-promoting effects in prostatic cancer via dual impact on miR-30a-5p by STAT3-MALAT1 and MYC. Cell Death Discov. 10, 159 (2024).","journal-title":"Cell Death Discov."},{"key":"65161_CR56","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/PAS.0b013e318124a865","volume":"32","author":"J Lapointe","year":"2008","unstructured":"Lapointe, J. et al. hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature. Am. J. Surg. Pathol. 32, 205\u2013209 (2008).","journal-title":"Am. J. Surg. Pathol."},{"key":"65161_CR57","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/pros.22940","volume":"75","author":"R Mitra","year":"2015","unstructured":"Mitra, R. & Goodman, O. B. Jr. CYP3A5 regulates prostate cancer cell growth by facilitating nuclear translocation of AR. Prostate 75, 527\u2013538 (2015).","journal-title":"Prostate"},{"key":"65161_CR58","doi-asserted-by":"crossref","unstructured":"Owe-Larsson, M. et al. The role of cocaine- and amphetamine-regulated transcript (CART) in cancer: a systematic review. Int. J. Mol. Sci. 24, 9986 (2023).","DOI":"10.3390\/ijms24129986"},{"key":"65161_CR59","doi-asserted-by":"publisher","first-page":"e0163232","DOI":"10.1371\/journal.pone.0163232","volume":"11","author":"S Liu","year":"2016","unstructured":"Liu, S. et al. Keratin 13 is enriched in prostate tubule-initiating cells and may identify primary prostate tumors that metastasize to the bone. PLoS ONE 11, e0163232 (2016).","journal-title":"PLoS ONE"},{"key":"65161_CR60","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ydbio.2020.11.012","volume":"473","author":"DB Joseph","year":"2021","unstructured":"Joseph, D. B., Turco, A. E., Vezina, C. M. & Strand, D. W. Progenitors in prostate development and disease. Dev. Biol. 473, 50\u201358 (2021).","journal-title":"Dev. Biol."},{"key":"65161_CR61","doi-asserted-by":"crossref","unstructured":"Sokol, C. L. & Luster, A. D. The chemokine system in innate immunity. Cold Spring Harb. Perspect. Biol. 7, a016303 (2015).","DOI":"10.1101\/cshperspect.a016303"},{"key":"65161_CR62","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","volume":"54","author":"AJ Ozga","year":"2021","unstructured":"Ozga, A. J., Chow, M. T. & Luster, A. D. Chemokines and the immune response to cancer. Immunity 54, 859\u2013874 (2021).","journal-title":"Immunity"},{"key":"65161_CR63","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5581\/v33n1a16","volume":"33","author":"GB de Carvalho","year":"2011","unstructured":"de Carvalho, G. B. & de Carvalho, G. B. Duffy Blood Group System and the malaria adaptation process in humans. Rev. Bras. Hematol. Hemoter. 33, 55\u201364 (2011).","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"65161_CR64","doi-asserted-by":"publisher","first-page":"1111960","DOI":"10.3389\/fimmu.2023.1111960","volume":"14","author":"KS Crawford","year":"2023","unstructured":"Crawford, K. S. & Volkman, B. F. Prospects for targeting ACKR1 in cancer and other diseases. Front. Immunol. 14, 1111960 (2023).","journal-title":"Front. Immunol."},{"key":"65161_CR65","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s10903-010-9330-z","volume":"13","author":"JK Elson","year":"2011","unstructured":"Elson, J. K. et al. The Duffy antigen\/receptor for chemokines (DARC) and prostate-cancer risk among Jamaican men. J. Immigr. Minor Health 13, 36\u201341 (2011).","journal-title":"J. Immigr. Minor Health"},{"key":"65161_CR66","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10903-013-9970-x","volume":"17","author":"B Nemesure","year":"2015","unstructured":"Nemesure, B., Wu, S. Y., Hennis, A. & Leske, M. C. Distribution of Duffy antigen receptor for chemokines (DARC) and risk of prostate cancer in Barbados, West Indies. J. Immigr. Minor Health 17, 679\u2013683 (2015).","journal-title":"J. Immigr. Minor Health"},{"key":"65161_CR67","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1096\/fj.05-4764com","volume":"20","author":"H Shen","year":"2006","unstructured":"Shen, H., Schuster, R., Stringer, K. F., Waltz, S. E. & Lentsch, A. B. The Duffy antigen\/receptor for chemokines (DARC) regulates prostate tumor growth. FASEB J. 20, 59\u201364 (2006).","journal-title":"FASEB J."},{"key":"65161_CR68","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1189\/jlb.3MR0915-431RR","volume":"99","author":"M Massara","year":"2016","unstructured":"Massara, M., Bonavita, O., Mantovani, A., Locati, M. & Bonecchi, R. Atypical chemokine receptors in cancer: friends or foes? J. Leukoc. Biol. 99, 927\u2013933 (2016).","journal-title":"J. Leukoc. Biol."},{"key":"65161_CR69","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1189\/jlb.3MR0915-401R","volume":"99","author":"A Mortier","year":"2016","unstructured":"Mortier, A., Gouwy, M., Van Damme, J., Proost, P. & Struyf, S. CD26\/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology. J. Leukoc. Biol. 99, 955\u2013969 (2016).","journal-title":"J. Leukoc. Biol."},{"key":"65161_CR70","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1182\/blood-2006-10-049072","volume":"110","author":"P Proost","year":"2007","unstructured":"Proost, P. et al. Proteolytic processing of CXCL11 by CD13\/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration. Blood 110, 37\u201344 (2007).","journal-title":"Blood"},{"key":"65161_CR71","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41416-021-01435-5","volume":"125","author":"F Ahmad","year":"2021","unstructured":"Ahmad, F., Cherukuri, M. K. & Choyke, P. L. Metabolic reprogramming in prostate cancer. Br. J. Cancer 125, 1185\u20131196 (2021).","journal-title":"Br. J. Cancer"},{"key":"65161_CR72","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.abb.2016.04.014","volume":"611","author":"LC Costello","year":"2016","unstructured":"Costello, L. C. & Franklin, R. B. A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer. Arch. Biochem. Biophys. 611, 100\u2013112 (2016).","journal-title":"Arch. Biochem. Biophys."},{"key":"65161_CR73","doi-asserted-by":"crossref","unstructured":"Hardie, D. G. Keeping the home fires burning: AMP-activated protein kinase. J. R. Soc. Interface 15, 20170774 (2018).","DOI":"10.1098\/rsif.2017.0774"},{"key":"65161_CR74","doi-asserted-by":"crossref","unstructured":"Schiliro, C. & Firestein, B. L. Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation. Cells 10, 1056 (2021).","DOI":"10.3390\/cells10051056"},{"key":"65161_CR75","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0022-5347(01)66357-2","volume":"155","author":"BE Persson","year":"1996","unstructured":"Persson, B. E. & Ronquist, G. Evidence for a mechanistic association between nonbacterial prostatitis and levels of urate and creatinine in expressed prostatic secretion. J. Urol. 155, 958\u2013960 (1996).","journal-title":"J. Urol."},{"key":"65161_CR76","doi-asserted-by":"publisher","unstructured":"McNaughton, C. O. & Wilt, T. Allopurinol for chronic prostatitis. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.CD001041 (2002).","DOI":"10.1002\/14651858.CD001041"},{"key":"65161_CR77","doi-asserted-by":"publisher","first-page":"751 e751","DOI":"10.1016\/j.fertnstert.2005.08.065","volume":"85","author":"RD Motrich","year":"2006","unstructured":"Motrich, R. D. et al. Uric acid crystals in the semen of a patient with symptoms of chronic prostatitis. Fertil. Steril. 85, 751 e751\u2013751.e754 (2006).","journal-title":"Fertil. Steril."},{"key":"65161_CR78","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nrc2090","volume":"7","author":"AM De Marzo","year":"2007","unstructured":"De Marzo, A. M. et al. Inflammation in prostate carcinogenesis. Nat. Rev. Cancer 7, 256\u2013269 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"65161_CR79","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.21037\/tcr-22-1297","volume":"11","author":"X Song","year":"2022","unstructured":"Song, X., Yuan, B., Zhao, S. & Zhao, D. Effect of taurine on the proliferation, apoptosis and MST1\/Hippo signaling in prostate cancer cells. Transl. Cancer Res. 11, 1705\u20131712 (2022).","journal-title":"Transl. Cancer Res."},{"key":"65161_CR80","doi-asserted-by":"crossref","unstructured":"Baliou, S. et al. Protective role of taurine against oxidative stress (Review). Mol. Med. Rep. 24, 605 (2021).","DOI":"10.3892\/mmr.2021.12242"},{"key":"65161_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32549-1","volume":"8","author":"MK Andersen","year":"2018","unstructured":"Andersen, M. K. et al. Integrative metabolic and transcriptomic profiling of prostate cancer tissue containing reactive stroma. Sci. Rep. 8, 14269 (2018).","journal-title":"Sci. Rep."},{"key":"65161_CR82","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/s41556-023-01274-x","volume":"25","author":"JM Giafaglione","year":"2023","unstructured":"Giafaglione, J. M. et al. Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment. Nat. Cell Biol. 25, 1821\u20131832 (2023).","journal-title":"Nat. Cell Biol."},{"key":"65161_CR83","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1159\/000019881","volume":"35","author":"R Montironi","year":"1999","unstructured":"Montironi, R., Hamilton, P. W., Scarpelli, M., Thompson, D. & Bartels, P. H. Subtle morphological and molecular changes in normal-looking epithelium in prostates with prostatic intraepithelial neoplasia or cancer. Eur. Urol. 35, 468\u2013473 (1999).","journal-title":"Eur. Urol."},{"key":"65161_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-73","volume":"6","author":"V Ananthanarayanan","year":"2006","unstructured":"Ananthanarayanan, V., Deaton, R. J., Yang, X. J., Pins, M. R. & Gann, P. H. Alteration of proliferation and apoptotic markers in normal and premalignant tissue associated with prostate cancer. BMC Cancer 6, 73 (2006).","journal-title":"BMC Cancer"},{"key":"65161_CR85","doi-asserted-by":"publisher","first-page":"189080","DOI":"10.1016\/j.bbcan.2024.189080","volume":"1879","author":"RI Skotheim","year":"2024","unstructured":"Skotheim, R. I., Bogaard, M., Carm, K. T., Axcrona, U. & Axcrona, K. Prostate cancer: molecular aspects, consequences, and opportunities of the multifocal nature. Biochim. Biophys. Acta Rev. Cancer 1879, 189080 (2024).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"65161_CR86","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/pros.21260","volume":"71","author":"H Bertilsson","year":"2011","unstructured":"Bertilsson, H. et al. A new method to provide a fresh frozen prostate slice suitable for gene expression study and MR spectroscopy. Prostate 71, 461\u2013469 (2011).","journal-title":"Prostate"},{"key":"65161_CR87","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/978-1-0716-3319-9_12","volume":"2688","author":"MK Andersen","year":"2023","unstructured":"Andersen, M. K. et al. Sample preparation for metabolite detection in mass spectrometry imaging. Methods Mol. Biol. 2688, 135\u2013146 (2023).","journal-title":"Methods Mol. Biol."},{"key":"65161_CR88","doi-asserted-by":"crossref","unstructured":"Andersen, M. K. et al. Spatial transcriptomics reveals strong association between SFRP4 and extracellular matrix remodeling in prostate cancer. Commun. Biol. 7, 1462 (2024).","DOI":"10.1038\/s42003-024-07161-x"},{"key":"65161_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"65161_CR90","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/PAS.0000000000000820","volume":"41","author":"JI Epstein","year":"2017","unstructured":"Epstein, J. I., Amin, M. B., Reuter, V. E. & Humphrey, P. A. Contemporary gleason grading of prostatic carcinoma: an update with discussion on practical issues to implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on gleason grading of prostatic carcinoma. Am. J. Surg. Pathol. 41, e1\u2013e7 (2017).","journal-title":"Am. J. Surg. Pathol."},{"key":"65161_CR91","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495\u2013502 (2015).","journal-title":"Nat. Biotechnol."},{"key":"65161_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28948-z","volume":"8","author":"DV Klopfenstein","year":"2018","unstructured":"Klopfenstein, D. V. et al. GOATOOLS: a Python library for Gene Ontology analyses. Sci. Rep. 8, 10872 (2018).","journal-title":"Sci. Rep."},{"key":"65161_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).","journal-title":"Genome Biol."},{"key":"65161_CR94","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","volume":"15","author":"M Efremova","year":"2020","unstructured":"Efremova, M., Vento-Tormo, M., Teichmann, S. A. & Vento-Tormo, R. CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat. Protoc. 15, 1484\u20131506 (2020).","journal-title":"Nat. Protoc."},{"key":"65161_CR95","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/nmeth.4077","volume":"13","author":"D Turei","year":"2016","unstructured":"Turei, D., Korcsmaros, T. & Saez-Rodriguez, J. OmniPath: guidelines and gateway for literature-curated signaling pathway resources. Nat. Methods 13, 966\u2013967 (2016).","journal-title":"Nat. Methods"},{"key":"65161_CR96","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902.e1821 (2019).","journal-title":"Cell"},{"key":"65161_CR97","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40170-021-00242-z","volume":"9","author":"MK Andersen","year":"2021","unstructured":"Andersen, M. K. et al. Spatial differentiation of metabolism in prostate cancer tissue by MALDI-TOF MSI. Cancer Metab. 9, 9 (2021).","journal-title":"Cancer Metab."},{"key":"65161_CR98","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1002\/mas.21794","volume":"42","author":"G Baquer","year":"2023","unstructured":"Baquer, G. et al. What are we imaging? Software tools and experimental strategies for annotation and identification of small molecules in mass spectrometry imaging. Mass Spectrom. Rev. 42, 1927\u20131964 (2023).","journal-title":"Mass Spectrom. Rev."},{"key":"65161_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-10-83","volume":"10","author":"T Wang","year":"2009","unstructured":"Wang, T. et al. Automics: an integrated platform for NMR-based metabonomics spectral processing and data analysis. BMC Bioinforma. 10, 83 (2009).","journal-title":"BMC Bioinforma."},{"key":"65161_CR100","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1021\/ac051632c","volume":"78","author":"F Dieterle","year":"2006","unstructured":"Dieterle, F., Ross, A., Schlotterbeck, G. & Senn, H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Anal. Chem. 78, 4281\u20134290 (2006).","journal-title":"Anal. Chem."},{"key":"65161_CR101","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jmr.2009.11.012","volume":"202","author":"F Savorani","year":"2010","unstructured":"Savorani, F., Tomasi, G. & Engelsen, S. B. icoshift: a versatile tool for the rapid alignment of 1D NMR spectra. J. Magn. Reson. 202, 190\u2013202 (2010).","journal-title":"J. Magn. Reson."},{"key":"65161_CR102","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/annonc\/mdx637","volume":"29","author":"S Jain","year":"2018","unstructured":"Jain, S. et al. Validation of a metastatic assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy. Ann. Oncol. 29, 215\u2013222 (2018).","journal-title":"Ann. Oncol."},{"key":"65161_CR103","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","volume":"173","author":"KA Hoadley","year":"2018","unstructured":"Hoadley, K. A. et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell 173, 291\u2013304.e296 (2018).","journal-title":"Cell"},{"key":"65161_CR104","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1200\/JCO.2016.70.2811","volume":"35","author":"DE Spratt","year":"2017","unstructured":"Spratt, D. E. et al. Individual patient-level meta-analysis of the performance of the decipher genomic classifier in high-risk men after prostatectomy to predict development of metastatic disease. J. Clin. Oncol. 35, 1991\u20131998 (2017).","journal-title":"J. Clin. Oncol."},{"key":"65161_CR105","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e3529 (2021).","journal-title":"Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65161-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65161-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65161-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:02:55Z","timestamp":1763560975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65161-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65161"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65161-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.A. and E.D. are employees and Y.H. is a former employee of Veracyte, Inc (San Diego, CA) who make the Decipher prostate genomic classifier test and own the GRID software\/database. The authors declare no further competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10160"}}